Quelles sont les heures d'ouverture ?

Lundi 09:00 - 18:00 Mardi 09:00 - 18:00 Mercredi 09:00 - 18:00 Jeudi 09:00 - 18:00 Vendredi 09:00 - 18:00

Visionix

We deeply believe that thorough research and understanding of the existing challenges and innovation

23/06/2026

How can OCT technology transform your clinical routine?

Join us for an exclusive webinar featuring Juan Bolívar Parra (DOO, FIAOMC, IACMM), a renowned international expert in advanced contactology and myopia control.

Key Takeaways:
>Protocol Updates: How to seamlessly integrate OCT into your anterior and posterior pole clinical practice.
>Early Detection: Key exams for fundus screening and identifying anterior abnormalities.
>Real-World Use Cases: Practical examples and clinical images using OCT Optovue iVue and SOLIX.

📅
Date: July 6th, 2026
Time: 5 PM (CEST)
Language: Presented in Spanish with English subtitles 🇬🇧 (Pre-recorded on March 26)
Don't miss this opportunity to learn from the Co-Chairman of the European Academy of Orthokeratology and Myopia Control

👉 Register now: https://eu1.hubs.ly/H0wn5D50

23/06/2026

What if OCT revolutionized your approach to dry eye?

In this article by Adil El Maftouhi, multimodal OCT imaging reveals its full potential for a comprehensive and objective analysis of the ocular surface.

👉 Epithelial mapping
👉 Tear film analysis
👉 Meibography
👉 En face imaging

These complementary modalities provide a deeper understanding of ocular surface imbalances and help refine your diagnosis.
With Solix, this approach becomes a reality: a complete, reproducible vision that is directly applicable to daily practice.

Thank you to Adil El Maftouhi for providing these clinical images.

At Visionix, we are convinced that multimodality is the key to improving dry eye management.

📖 Read the full article https://eu1.hubs.ly/H0tV09-0

18/06/2026

A major report from the American Academy of Ophthalmology (AAO) highlights the value of instrument-based screening in the early detection of amblyopia and amblyopia risk factors in children.

Among the technologies evaluated, Retinomax is one of the most widely studied handheld autorefractors used in clinical practice.

Why do eye care professionals choose Retinomax?

-Strong screening sensitivity: Across multiple studies, Retinomax has demonstrated sensitivity ranging from approximately 70% to 95% in detecting amblyopia risk factors—supporting early identification of conditions such as astigmatism and hyperopia.

-Controlled, eye-by-eye measurement: Its targeted monocular assessment enables reliable refractive data (sphere and cylinder) in screening environments.

-Built-in quality control : With an integrated confidence indicator, practitioners can assess measurement quality in real time—supporting consistent screening outcomes, even in schools and outreach settings.

Retinomax supports reliable, accessible vision screening, helping more children receive timely care when it matters most.
Full report available at: https://eu1.hubs.ly/H0tV1Pk0

More about the Retinomax series on https://eu1.hubs.ly/H0tT_bk0

16/06/2026

Meibography: After the acquisition, how do you interpret the results?
With Solix, Meibomian gland imaging is fast and simple… but the key challenge remains the analysis.

To guide interpretation, the Meibomian gland atrophy classification proposed by Pr. Dighiero provides a structured reading:
Stage 1: Mild involvement
Stage 2: Moderate atrophy
Stage 3: Severe atrophy

This approach facilitates:
✔️ Standardized assessment
✔️ Improved long-term monitoring
✔️ Clinical decision support

Combined with Solix’s superior image quality, it allows for the full integration of meibography into daily practice and dry eye management.

Thank you to Professor Pablo Dighiero for providing these clinical images.

At Visionix, we develop solutions that go beyond data acquisition to support practitioners all the way through to interpretation.

More about Optovue Solix on https://eu1.hubs.ly/H0tV1Pf0

11/06/2026

As we refine our approach to glaucoma, a fundamental question remains: Is OCTA simply a diagnostic "snapshot," or is it the key to identifying your most vulnerable patients before functional loss occurs? In this third part of our 5-post series featuring Dr. Sayeh Pourjavan, we dive into the strategic utility of vascular imaging: "Do you see OCTA primarily as a diagnostic tool or as a method for risk assessment and stratification?“

See her full answer in the video! 📽️

More about Optovue Solix on https://eu1.hubs.ly/H0tT-lS0

09/06/2026

Meibography has never been easier with Solix.
Thanks to its high-resolution multimodal technology, capturing images of the Meibomian glands with Solix is both quick and simple.

👉 Seamless acquisition in seconds
👉 Superior image quality
👉 Natural integration into your consultation workflow

With no additional equipment required, everything is performed on a single platform for a more efficient practice and improved ocular surface management.

At Visionix, we develop solutions that combine ease of use with clinical excellence.
https://eu1.hubs.ly/H0tV04S0

04/06/2026

Did you know that Solix is one of the few OCT capable of performing meibography?

Thanks to its ultra-high-resolution multimodal imaging technology, everything is done on a single platform: no extra equipment is needed to examine the Meibomian glands.
👉 Fewer devices
👉 Saves space in the practice
👉 Saves time during consultations
👉 Optimized investment

The Solix expands the scope of examinations—from the retina to the ocular surface—for more comprehensive and efficient patient care, particularly for dry eye management.

At Visionix, we design solutions that simplify your practice while maximizing clinical value.
https://eu1.hubs.ly/H0tT_sy0

Adresse

2 Rue Roger Bonnet
Pont-de-l'Arche
27340

Heures d'ouverture

Lundi	09:00 - 18:00
Mardi	09:00 - 18:00
Mercredi	09:00 - 18:00
Jeudi	09:00 - 18:00
Vendredi	09:00 - 18:00

Téléphone

+33 (0)2 32 98 91 32

Site Web

https://www.visionix.com/

Notifications

Soyez le premier à savoir et laissez-nous vous envoyer un courriel lorsque Visionix publie des nouvelles et des promotions. Votre adresse e-mail ne sera pas utilisée à d'autres fins, et vous pouvez vous désabonner à tout moment.